National Bank of Canada’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,365
Closed -$35.6M 2835
2024
Q4
$35.6M Buy
+1,365
New +$405K 0.04% 395

Other funds holding AMGN

National Bank of Canada's AMGN Position: Q1 2026 in Review

National Bank of Canada reduced its Amgen (AMGN) stake by 38% in Q1 2026, selling an estimated $90.9M and leaving 420,993 shares worth $148M. The position accounts for 0.13% of the portfolio, ranked #135.

National Bank of Canada first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $346M in Q3 2025. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • National Bank of Canada held 420,993 shares of Amgen worth $148M as of Q1 2026.
  • National Bank of Canada sold 254,963 Amgen shares in Q1 2026, an estimated $90.9M.
  • Amgen made up 0.13% of National Bank of Canada's portfolio in Q1 2026, its #135 holding.
  • National Bank of Canada first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Amgen position peaked at $346M in Q3 2025.
  • 3,133 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.